Provided by Tiger Fintech (Singapore) Pte. Ltd.

Arvinas Holding Company LLC

7.73
-0.0300-0.39%
Post-market: 7.730.00000.00%19:27 EDT
Volume:735.47K
Turnover:5.67M
Market Cap:567.52M
PE:-7.71
High:7.85
Open:7.82
Low:7.63
Close:7.76
52wk High:29.61
52wk Low:5.90
Shares:73.42M
Float Shares:68.51M
Volume Ratio:0.46
T/O Rate:1.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0021
EPS(LYR):-2.7663
ROE:-12.00%
ROA:-6.71%
PB:0.93
PE(LYR):-2.79

Loading ...

BRIEF-Logos Global Management Reports 8.6% Stake In Arvinas

Reuters
·
Aug 23

Logos Global Management Lp Reports 8.6% Stake in Arvinas as of Aug 15 VS 6.4% as of June 9 - SEC Filing

THOMSON REUTERS
·
Aug 23

Logos Global Management Lp - Letter Urged Arvinas Board to Return $700 Million of Capital to Stockholders

THOMSON REUTERS
·
Aug 23

Logos Global Management-Letter Urged Arvinas Board to Allow Co's Valuation to Rebase Around Its Core Science, Execute a 1-for-5 Reverse Stock Split

THOMSON REUTERS
·
Aug 23

Piper Sandler Keeps Their Buy Rating on Arvinas Holding Company (ARVN)

TIPRANKS
·
Aug 11

Arvinas, Pfizer announce FDA acceptance of vepdegestrant NDA

TIPRANKS
·
Aug 09

Arvinas and Pfizer's Vepdegestrant NDA Accepted by FDA for ESR1m, ER+/HER2- Advanced Breast Cancer Treatment

Reuters
·
Aug 09

Arvinas Announces FDA Acceptance of the New Drug Application for Vepdegestrant for the Treatment of Esr1m, Er+/Her2- Advanced Breast Cancer

THOMSON REUTERS
·
Aug 09

Arvinas Inc - FDA Assigns Pdufa Action Date of June 5, 2026

THOMSON REUTERS
·
Aug 09

Arvinas Inc - Vepdegestrant Granted Fast Track Designation by FDA

THOMSON REUTERS
·
Aug 09

Truist Cuts Price Target on Arvinas to $10 From $11, Keeps Hold Rating

MT Newswires Live
·
Aug 08

Arvinas Inc : Truist Securities Cuts Target Price to $10 From $11

THOMSON REUTERS
·
Aug 08

Arvinas Holding Company (ARVN) Gets a Buy from Guggenheim

TIPRANKS
·
Aug 07

Morgan Stanley Lowers Price Target on Arvinas to $10 From $11, Keeps Equalweight Rating

MT Newswires Live
·
Aug 07

Barclays Sticks to Its Buy Rating for Arvinas Holding Company (ARVN)

TIPRANKS
·
Aug 07

Stock Track | Arvinas Plummets 6.44% as Q2 Revenue Misses Estimates and CEO Announces Retirement

Stock Track
·
Aug 06

Arvinas Inc. Unveils Presentation on Transformative Advances in Cancer and Neurodegenerative Disease Therapies

Reuters
·
Aug 06

Arvinas Q2 Revenue USD 22.4 Million

Reuters
·
Aug 06

Arvinas reports Q2 EPS (84c), consensus (89c)

TIPRANKS
·
Aug 06

Arvinas Says Cash, Cash Equivalents, And Marketable Securities Of $861.2M As Of June 30, 2025, Is Sufficient To Fund Planned Operating Expenses And Capital Expenditure Requirements Into 2H Of 2028

Benzinga
·
Aug 06